'Evolving' With Health Care, CHPA Considers Device, Supplement Sectors
Executive Summary
CHPA's 2020 project is an internal analysis on how it can evolve as its members broaden into additional business categories. President and CEO Scott Melville says the effort is necessary to keep up with the “lightning speed” of health care changes.
You may also be interested in...
CHPA Eyes Spanning Self-Care Space With Bridge To Device Sector
Many CHPA members also market medical devices "and the consumer side of medical devices is something they feel is underrepresented by other trade associations,” says trade group head Scott Melville. OTC drugs already have “a lot in common” with consumer medical devices, including that paying for neither typically is included in health insurance plans.
CHPA Eyes Spanning Self-Care Space With Bridge To Device Sector
Many CHPA members also market medical devices "and the consumer side of medical devices is something they feel is underrepresented by other trade associations,” says trade group head Scott Melville. OTC drugs already have “a lot in common” with consumer medical devices, including that paying for neither typically is included in health insurance plans.
OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA
Imminent OTC monograph reform legislation signals an agreement between industry and FDA on details of a proposal, which also includes a potential user fee program. CHPA also is hopeful for legislation restoring direct OTC drug purchases with pre-tax savings accounts.